Summary
Updated Aug 30, 2026
Amit Hasija is CFO & EVP of Corp. Development of Milestone Pharmaceuticals Inc. (MIST). 4 SEC Form 4 filings on record going back to 2025, most recently on 5 February 2026. Most recent open-market trade: sold $24K of MIST on 28 January 2026. Lifetime open-market sales: $158K.
Recent Transactions
5Every recent SEC Form 4 transaction Amit Hasija has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Amit Hasija files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joseph Oliveto - $556K of MIST open-market activity in the last 12 months
- David Bharucha - $158K of MIST open-market activity in the last 12 months
- Jeffrey Edward Nelson - $158K of MIST open-market activity in the last 12 months
- Lorenz Muller - $146K of MIST open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Amit Hasija?
Amit Hasija is a corporate insider, tracked as CFO & EVP of Corp. Development of Milestone Pharmaceuticals Inc. (MIST). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Amit Hasija last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 4 filings going back to 2025.
Has Amit Hasija been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($158K) across all tracked filings.
Where can I see all of Amit Hasija's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Amit Hasija and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
